Newsroom

Categories

New technology will be used to enhance current microTargeting Platform production capabilities

In order to better serve the needs of neurosurgeons worldwide, FHC has invested in new technology that will enhance the production process our microTargeting™ Platform featuring STarFix™ Technology. FHC’s Greenville, Pennsylvania location recently acquired the EOS Formiga P 110, a laser sintering 3D printer, to help meet a growing demand for the patient-personalized platforms.  

The new machine sinters plastic using a 30-watt CO2 laser, allowing it to manufacture products with a complex internal geometry.  According to Tim Williams, GNS Vice President, the new P 110 machine is able to print platforms 30% faster than the P 100 model already used by FHC.  Both machines will be used in the future to allow platform orders to be processed more efficiently.

FHC’s microTargeting Platform is a patient-customized frameless stereotactic device that transforms functional neurosurgery from a marathon surgical event, which routinely immobilizes an awake patient for up to 12 hours, into an outpatient scanning visit followed by a shorter surgery with the use of the incorporated STarFix technology.  Learn more about our microTargeting Platform by clicking here.

Categories

Close
Leave blank for all. Otherwise, the first selected term will be the default instead of "Any".

Browse through FHC’s wide array of neurosurgical research equipment

View Our Products